Micro-X logo

Micro-X(ASX) MX1

Market CapA$48.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-89%
5 Year-79%
1 Year-34%
1 Month+276%
A$0.06
+18.52%
+0.01Today
Micro-X last closing stock price
MetricPriceDate
Last closeAUD 0.062026-10-09
Micro-X stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.23%AUD 0.062026-10-02
1 month+276.47%AUD 0.022026-09-09
3 month+93.94%AUD 0.032026-07-10
Year to date-39.05%AUD 0.112025-12-31
1 year-34.02%AUD 0.102025-10-09
3 year-54.29%AUD 0.142023-10-10
5 year-79.35%AUD 0.312021-10-08
Since inception-88.93%AUD 0.582015-12-22

Micro-X Financials at a Glance

Market Cap

A$48.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$28.14M

Net Income (TTM)

-A$23.77M

EPS (TTM)

-A$0.01

P/E Ratio

-4.51

Dividend

A$0.00

Beta (Volatility)

-0.17 (Low)

Price

A$0.06

Volume

9,775,957

Open

A$0.06

Previous Close

A$0.06

Daily Range

A$0.05 - A$0.08

52-Week Range

A$0.01 - A$0.12

Estimated Earnings Date

Feb 26, 2027

MX1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Micro-X

Micro-X Limited is an innovative company specializing in the design, development, and manufacturing of imaging products for healthcare, defense, and security markets. Utilizing advanced cold cathode X-ray technology, Micro-X offers a range of carbon nanotube-based X-ray products that enhance medical imaging capabilities.

Products and Services
  • Core X-ray tube and high-voltage generator components
  • Rover Plus for mobile medical imaging systems
  • Checkpoints for passenger self-screening at airports
Growth Outlook
  • Recent revenue of AUD 4.98 million indicates potential for recovery
  • Expansion into international markets enhances growth opportunities
  • Innovative product offerings position the company for future demand
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 10.1 million
  • Net income for the latest quarter was AUD -3.26 million
  • Current ratio of 1.33 suggests adequate short-term liquidity
Micro-X Limited operates in a competitive landscape, focusing on advanced imaging technologies that cater to critical sectors. The company's innovative approach, particularly in mobile medical imaging, positions it well for future growth. Recent financial performance shows a revenue of AUD 4.98 million in the latest quarter, reflecting a potential recovery trajectory. The expansion into international markets and a strong product pipeline further enhance the company's growth prospects. With a current ratio of 1.33, Micro-X demonstrates a solid liquidity position, which is crucial for navigating operational challenges. Overall, Micro-X Limited presents an intriguing opportunity for investors interested in the medical devices sector.
AI Generated • Sep 16, 2026

Industry

Healthcare Equipment and Supplies

CEO

Kingsley Campbell Hall

Headquarters

Adelaide, SA 5042, AU

MX1 Financials

Key Financial Metrics (TTM)

Gross Margin

-60.66%

Operating Margin

-104.71%

Net Income Margin

-65.46%

Return on Equity

-188.06%

Return on Capital

-138.70%

Return on Assets

-50.09%

Earnings Yield

-22.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$48.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

752.44M

Volume

9.78M

Avg. Volume

1.56M

Financials (TTM)

Gross Profit

-A$3.17M

Operating Income

-A$29.09M

EBITDA

-A$30.61M

Operating Cash Flow

-A$17.51M

Capital Expenditure

-A$244.00K

Free Cash Flow

-A$17.76M

Cash & ST Invst.

A$3.14M

Total Debt

A$6.48M

Micro-X Performance Analysis

Micro-X annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 15,005,00067.3%
20242024-06-30AUD 15,222,0001.4%
20252025-06-30AUD 13,053,000-14.2%
20262026-06-30AUD 15,087,00015.6%
Micro-X sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-315.3%
Q42025-06-30-23.6%
Q22025-12-3178.8%
Q42026-06-30-50.7%
Micro-X annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-41.6%
20242024-06-30AUD -0.02-14.4%
20252025-06-30AUD -0.0223.9%
20262026-06-30AUD -0.01-38.2%
Micro-X sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-282.1%
Q42025-06-3045.0%
Q22025-12-31-20.7%
Q42026-06-3055.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$4.98M

-29.1%

Gross Profit

-A$6.66M

-314.3%

Gross Margin

-1.34%

N/A

Market Cap

A$48.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$6.07K

N/A

Employees

7,935

N/A

Net Income

-A$3.26M

-55.0%

EBITDA

-A$9.63M

-26.7%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$3.14M

-2.9%

Total Debt

A$6.48M

+62.4%

Accounts Receivable

A$7.39M

-27.3%

Inventory

A$4.02M

-25.3%

Long Term Debt

A$2.74M

-16.8%

Short Term Debt

A$3.74M

+439.7%

Return on Assets

-50.09%

N/A

Return on Invested Capital

-1.88%

N/A

Free Cash Flow

-A$6.01M

+17.0%

Operating Cash Flow

-A$5.88M

+17.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CMP.AXCompumedics Limited
A$0.25-5.77%
MVP.AXMedical Developments International Limited
A$0.42-2.35%
M7T.AXMach7 Technologies Limited
A$0.22-2.27%
SHG.AXSingular Health Group Ltd
A$0.17-2.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.18-9.81%
WFFWf
$12.29+499.51%
VZVerizon Communications
$41.65-8.75%
SPCXSpace Exploration Technologies
$162.57+1.25%

Questions About MX1

What is the current price of Micro-X?

Micro-X is trading at A$0.06 per share.

What is the 52-week range for Micro-X?

Over the past 52 weeks, Micro-X has traded between A$0.01 and A$0.12.

How much debt does Micro-X have?

As of the most recent reporting period, Micro-X reported total debt of A$6.52M.

How much cash does Micro-X have on hand?

Micro-X reported A$3.14M in cash and cash equivalents in its most recent financial results.

What is Micro-X’s dividend yield?

Micro-X does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.